AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Rifabutin in Nigeria
1 product registered with NAFDAC — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Mycobutin Capsules 150 mg** Capsule | A4-4726 | Pfizer Specialties Ltd | active | 29 Nov 2025 |
Rifabutin — NAFDAC Registration Details
NAFDAC (Nigeria) has 1 registered product containing Rifabutin, of which 1 is currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Rifabutin registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.